Similar articles

• Laboratory parameters as discriminators for peripheral atherosclerosis and stroke.

  Kostner GM, Marth E, Pfeiffer KH, Wege H. Kostner GM, et al. Monogr Atheroscler. 1986;14:119-23. Monogr Atheroscler. 1986. PMID: 3736549 No abstract available.
• [Differential use of apolipoproteins and lipoproteins as discriminators for atherogenic risk].

  Mertz DP, Göhmann E, Ostertag J. Mertz DP, et al. Med Welt. 1981 Oct 23;32(43):1611-5. Med Welt. 1981. PMID: 7300661 German. No abstract available.
• [From cholesterol to lipoprotein particle markers and/or risk factors].

  Fruchart JC, Cottet J. Fruchart JC, et al. Bull Acad Natl Med. 1991 Jan;175(1):51-62; discussion 62-5. Bull Acad Natl Med. 1991. PMID: 1863858 French.
• [Less well-known lipid "risk" factors of arteriosclerosis].

  Pagnan A, Zanetti G, Guarini P, Dal Palú C. Pagnan A, et al. G Clin Med. 1980 Aug;61(8):593-600. G Clin Med. 1980. PMID: 7004983 Review. Italian. No abstract available.
• Impact of hormone replacement therapy on serum lipids, lipoproteins, body composition, and atherosclerosis: clinical and experimental studies.

  Haarbo J. Haarbo J. Dan Med Bull. 1994 Sep;41(4):412-22. Dan Med Bull. 1994. PMID: 7813250 Review. No abstract available.